Walleye Trading’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.4M Buy
1,044,200
+572,100
+121% +$27.1M 0.06% 298
2025
Q4
$24M Buy
472,100
+71,300
+18% +$3.65M 0.03% 541
2025
Q3
$22.2M Buy
400,800
+265,400
+196% +$15.5M 0.03% 548
2025
Q2
$9.35M Sell
135,400
-22,000
-14% -$1.5M 0.02% 851
2025
Q1
$10.9M Buy
157,400
+33,000
+27% +$2.73M 0.03% 675
2024
Q4
$10.7M Buy
124,400
+101,900
+453% +$11M 0.02% 754
2024
Q3
$2.68M Buy
22,500
+800
+4% +$107K 0.01% 1498
2024
Q2
$3.1M Sell
21,700
-31,300
-59% -$4.15M 0.01% 1331
2024
Q1
$6.81M Buy
53,000
+10,600
+25% +$1.26M 0.01% 929
2023
Q4
$4.39M Sell
42,400
-24,100
-36% -$2.38M 0.01% 1321
2023
Q3
$6.05M Sell
66,500
-54,900
-45% -$4.84M 0.02% 978
2023
Q2
$9.82M Sell
121,400
-31,200
-20% -$2.55M 0.03% 594
2023
Q1
$12.1M Sell
152,600
-34,000
-18% -$2.41M 0.03% 549
2022
Q4
$12.6M Sell
186,600
-12,800
-6% -$750K 0.04% 536
2022
Q3
$9.93M Buy
199,400
+9,600
+5% +$514K 0.03% 628
2022
Q2
$10.6M Buy
189,800
+183,000
+2,691% +$10.2M 0.03% 576
2022
Q1
$378K Sell
6,800
-45,400
-87% -$2.33M ﹤0.01% 3197
2021
Q4
$2.92M Buy
52,200
+21,800
+72% +$1.18M 0.01% 1342
2021
Q3
$1.46M Buy
30,400
+14,600
+92% +$706K 0.01% 1861
2021
Q2
$662K Buy
15,800
+11,400
+259% +$442K ﹤0.01% 2588
2021
Q1
$148K Sell
4,400
-83,200
-95% -$2.96M ﹤0.01% 3872
2020
Q4
$3.06M Sell
87,600
-8,800
-9% -$304K 0.01% 1061
2020
Q3
$3.35M Buy
96,400
+41,400
+75% +$1.38M 0.02% 795
2020
Q2
$1.8M Buy
55,000
+11,400
+26% +$364K 0.01% 1186
2020
Q1
$1.31M Sell
43,600
-6,200
-12% -$185K 0.01% 1114
2019
Q4
$1.44M Sell
49,800
-27,800
-36% -$770K 0.01% 1485
2019
Q3
$2.01M Sell
77,600
-73,400
-49% -$1.86M 0.02% 1031
2019
Q2
$3.85M Buy
151,000
+42,400
+39% +$1.05M 0.03% 615
2019
Q1
$2.84M Buy
108,600
+14,600
+16% +$359K 0.02% 817
2018
Q4
$2.17M Sell
94,000
-36,800
-28% -$818K 0.02% 1016
2018
Q3
$3.08M Buy
130,800
+111,200
+567% +$2.71M 0.02% 971
2018
Q2
$452K Buy
19,600
+18,600
+1,860% +$442K ﹤0.01% 2940
2018
Q1
$25K Sell
1,000
-63,800
-98% -$1.68M ﹤0.01% 4273
2017
Q4
$1.74K Sell
64,800
-168,200
-72% -$4.28M 0.01% 1426
2017
Q3
$5.61K Buy
233,000
+201,000
+628% +$4.54M 0.03% 595
2017
Q2
$688 Sell
32,000
-31,600
-50% -$638K ﹤0.01% 2088
2017
Q1
$1.09K Buy
63,600
+53,400
+524% +$930K 0.01% 1572
2016
Q4
$185K Sell
10,200
-101,800
-91% -$1.85M ﹤0.01% 2843
2016
Q3
$2.33M Sell
112,000
-63,000
-36% -$1.56M 0.02% 877
2016
Q2
$4.71M Buy
175,000
+152,400
+674% +$4.18M 0.03% 474
2016
Q1
$613K Buy
22,600
+10,200
+82% +$273K 0.01% 1803
2015
Q4
$361K Buy
12,400
+9,600
+343% +$266K ﹤0.01% 2149
2015
Q3
$75K Sell
2,800
-24,400
-90% -$691K ﹤0.01% 3176
2015
Q2
$745K Buy
27,200
+5,800
+27% +$163K 0.01% 1344
2015
Q1
$572K Buy
21,400
+15,400
+257% +$355K 0.01% 1393
2014
Q4
$127K Sell
6,000
-4,800
-44% -$107K ﹤0.01% 2639
2014
Q3
$257K Buy
10,800
+1,400
+15% +$32.2K ﹤0.01% 1869
2014
Q2
$216 Buy
9,400
+4,200
+81% +$92.7K ﹤0.01% 1941
2014
Q1
$119 Sell
5,200
-27,800
-84% -$592K ﹤0.01% 2269
2013
Q4
$608K Buy
+33,000
New +$575K 0.01% 1439

Other funds holding NVO

Walleye Trading's NVO Position: Q1 2026 in Review

Walleye Trading increased its Novo Nordisk (NVO) stake by 11% in Q1 2026, buying an estimated $1.71M and bringing the position to 378,650 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #643.

Walleye Trading first reported a position in NVO in Q2 2013 and has held it in 26 quarters since. The position peaked at $52.5M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Walleye Trading held 378,650 shares of Novo Nordisk worth $13.9M as of Q1 2026.
  • Walleye Trading bought 36,143 Novo Nordisk shares in Q1 2026, an estimated $1.71M.
  • Novo Nordisk made up 0.02% of Walleye Trading's portfolio in Q1 2026, its #643 holding.
  • Walleye Trading first reported a position in Novo Nordisk in Q2 2013 and has held it in 26 quarters since.
  • Walleye Trading's Novo Nordisk position peaked at $52.5M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.